Re-Earning the Public Trust
This article was originally published in RPM Report
Executive Summary
Pharma has made big changes in marketing and promotion practices and the systems to assure compliance, but the industry’s ethical image is lagging the efforts at reform. Pfizer Specialty Care/Oncology President Geno Germano says a shared commitment among companies to convince the public of the impact of the industry’s compliance reforms is the key to a healthy environment for the industry.